Great Plains Chapter of the American College of Cardiology

Latest in Cardiology from ACC.org

• Early Administration of Heparin at First Medical Contact for PPCI of STEMI Patients
  The goal of the HELP-PCI trial was to determine the efficacy and safety of administering unfractionated heparin at first medical contact versus during cardiac catheterization only in patients with ST-segment elevation myocardial infarction (STEMI).
• HELIOS-B Analyses: Vutrisiran Significantly Affects Biomarkers, Echocardiographic Parameters
  Two post-hoc analyses of the HELIOS-B trial published Aug. 4 in JACC found that vutrisiran had significant effect on both biomarkers like NT-proBNP and troponin I levels and echocardiographic measures of biventricular systolic and diastolic function in patients with transthyretin amyloidosis cardiomyopathy (ATTR-CM). Furthermore, both these biomarkers and echocardiographic measures provide critical prognostic information.
• FDA Update: Boston Scientific Warns of WATCHMAN Access System Issue
  The U.S. Food and Drug Administration (FDA) has announced that certain WATCHMAN Access Systems have updated use instructions to address risk of air embolism.
• ACCEL Lite: LAAO vs. DOAC for Stroke Prevention in AFib
  In this interview, Drs. Anthony N. DeMaria and Dhanunjaya Lakkireddy explore the evolving landscape of stroke prevention in patients with atrial fibrillation, focusing on the comparison between traditional blood thinners and LAAO.
• Cardiovascular Care of the Pediatric Athlete: A Timely Guide in Leveling the Playing Field for Young Athletes
  The JACC state-of-the-art review on the Cardiovascular Care of the Pediatric Athlete is a comprehensive and timely guide for providers managing cardiovascular (CV) health in pediatric athletes, defined as individuals 5-17 years of age who participate in organized and recreational sports.